Franklin Genomic Advancements ETF Rating $27.21 +0.05 (+0.20%) Closing price 06/13/2025 02:33 PM EasternExtended Trading$27.32 +0.10 (+0.38%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.77Holdings in HELX have an aggregate rating of Moderate Buy based on 755 analyst ratings issued in the past year covering 54 companies (87.0% of the portfolio).HELX Aggregate Price Target$27.21High Prediction$27.21Average Prediction$27.21Low Prediction$27.21Holdings in HELX have an aggregate price target of $27.21 and a range of $27.21 to $27.21 covering 54 companies (87.0% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy36 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 54 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.39%NTRANatera$165.34+0.6%1.8551 of 5 stars3.00$184.63 11.7%15Positive NewsInsider Trade4.60%VRTXVertex Pharmaceuticals$455.45-1.0%4.6356 of 5 stars2.57$515.04 13.1%30Positive NewsAnalyst Revision3.43%MEDPMedpace$298.25-1.9%4.6506 of 5 stars2.23$349.30 17.1%13Positive News3.41%KRYSKrystal Biotech$137.07-2.3%4.48 of 5 stars3.00$211.13 54.0%9Positive NewsAnalyst Revision3.38%ALNYAlnylam Pharmaceuticals$307.99+1.1%4.2484 of 5 stars2.77$319.58 3.8%26Positive NewsAnalyst Forecast3.35%UTHRUnited Therapeutics$283.35-1.0%4.9928 of 5 stars2.69$393.08 38.7%13Positive NewsAnalyst ForecastInsider TradeAnalyst Revision3.28%CTVACorteva$72.36-0.2%4.0441 of 5 stars2.80$70.92 -2.0%153.27%LLYEli Lilly and Company$818.56+0.8%4.8026 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision3.07%GHGuardant Health$49.29+0.6%3.7384 of 5 stars3.00$53.76 9.1%21Analyst Forecast2.99%BNTXBioNTech$106.57+1.6%2.823 of 5 stars2.83$138.25 29.7%18Trending News2.97%AZNAstraZeneca$74.42-0.8%2.859 of 5 stars3.13$85.00 14.2%8Positive NewsAnalyst Revision2.55%REGNRegeneron Pharmaceuticals$529.24+1.4%4.8812 of 5 stars2.85$836.48 58.1%26Positive NewsAnalyst Revision2.38%INSMInsmed$98.73+1.9%3.2856 of 5 stars3.00$104.81 6.2%18Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume2.29%CDNSCadence Design Systems$300.00-2.5%4.3478 of 5 stars2.77$325.23 8.4%13Positive News2.16%TMOThermo Fisher Scientific$402.12-3.2%4.9696 of 5 stars2.80$605.30 50.5%20Trending News2.11%BBIOBridgeBio Pharma$39.78+0.3%4.6137 of 5 stars2.92$57.36 44.2%12Insider TradeAnalyst Revision1.98%RAREUltragenyx Pharmaceutical$37.49-4.6%4.4118 of 5 stars2.92$88.77 136.8%13Analyst Revision1.93%DHRDanaher$200.51-2.2%4.8163 of 5 stars2.80$248.17 23.8%20Positive News1.93%EXASExact Sciences$53.52-0.9%4.6051 of 5 stars2.95$70.90 32.5%22News CoveragePositive News1.83%TEMTempus AI$71.220.0%1.6568 of 5 stars2.54$63.42 -11.0%13Trending NewsInsider TradeGap Down1.74%QGENQiagen$47.08-0.7%3.179 of 5 stars2.30$48.42 2.8%101.64%ADPTAdaptive Biotechnologies$10.32-0.9%2.5522 of 5 stars2.83$9.83 -4.7%6Positive NewsGap Down1.59%TWSTTwist Bioscience$33.52-0.3%4.1079 of 5 stars2.70$50.40 50.4%10Gap Down1.58%LGNDLigand Pharmaceuticals$112.50-1.7%4.3938 of 5 stars3.00$146.14 29.9%7News CoveragePositive News1.37%LHLaboratory Co. of America$260.84-0.3%4.4128 of 5 stars2.86$274.00 5.0%14Positive NewsAnalyst ForecastInsider Trade1.32%AAgilent Technologies$116.97-1.6%4.5261 of 5 stars2.50$140.15 19.8%14Analyst DowngradeAnalyst Revision1.31%CRLCharles River Laboratories International$149.50-1.6%4.7046 of 5 stars2.18$171.85 14.9%17Gap Down1.29%RGENRepligen$127.52-2.9%4.7683 of 5 stars2.64$173.25 35.9%141.18%NBIXNeurocrine Biosciences$124.39-0.5%4.9103 of 5 stars2.86$162.00 30.2%22Positive NewsAnalyst Revision1.04%DOCSDoximity$55.92-1.8%3.5278 of 5 stars2.59$62.84 12.4%221.02%BMRNBioMarin Pharmaceutical$56.22-1.9%4.9385 of 5 stars2.74$93.45 66.2%23Positive NewsAnalyst Revision0.97%RVTYRevvity$93.47-2.3%3.8532 of 5 stars2.80$125.64 34.4%15Positive News0.89%VCYTVeracyte$26.44-0.9%4.0674 of 5 stars2.70$40.90 54.7%10Positive NewsAnalyst Upgrade0.88%IQVIQVIA$156.65-1.6%4.885 of 5 stars2.75$226.32 44.5%24Short Interest ↑0.84%GRALGrail$41.31-1.5%0.4595 of 5 stars2.25$31.50 -23.7%4Gap Down0.82%RXRXRecursion Pharmaceuticals$4.92-4.8%1.9289 of 5 stars2.33$7.60 54.5%6Analyst RevisionGap DownHigh Trading Volume0.80%CPRXCatalyst Pharmaceuticals$23.53-3.1%4.7678 of 5 stars3.25$32.83 39.5%8Gap Down0.77%SDGRSchrödinger$21.43-6.1%2.4877 of 5 stars3.00$32.80 53.1%60.65%DVAXDynavax Technologies$10.27-1.3%4.1222 of 5 stars2.50$24.00 133.7%40.64%TECHBio-Techne$50.52-2.0%4.8525 of 5 stars2.45$72.00 42.5%11Gap Down0.63%BEAMBeam Therapeutics$17.06-2.2%3.0661 of 5 stars3.00$48.75 185.8%15Analyst RevisionGap Down0.62%IONSIonis Pharmaceuticals$35.59-0.1%4.3747 of 5 stars2.68$57.59 61.8%19News CoverageAnalyst Forecast0.60%BIOBio-Rad Laboratories$227.43-2.1%4.7522 of 5 stars2.75$324.25 42.6%4Analyst Revision0.55%BMYBristol-Myers Squibb$49.71-1.9%4.8453 of 5 stars2.32$58.00 16.7%22Positive NewsAnalyst Revision0.55%BRKRBruker$38.30-3.9%4.9667 of 5 stars2.40$56.22 46.8%100.52%PTCTPTC Therapeutics$51.26+0.5%3.8423 of 5 stars2.64$63.75 24.4%14Analyst RevisionGap Down0.38%WGSGeneDx$64.57-2.7%3.6847 of 5 stars2.75$86.75 34.4%8News CoverageGap Down0.34%TVTXTravere Therapeutics$14.50-2.9%2.4722 of 5 stars2.87$32.14 121.7%15Trending NewsAnalyst ForecastAnalyst Revision0.29%CRSPCRISPR Therapeutics$41.36+0.2%3.2805 of 5 stars2.50$71.75 73.5%18Analyst RevisionGap Down0.25%CDNACareDx$18.59-1.3%3.7209 of 5 stars2.67$30.33 63.2%6Insider TradeGap Down0.18%WVEWave Life Sciences$6.95-3.5%4.2523 of 5 stars2.92$20.50 195.0%12News CoverageAnalyst ForecastInsider TradeAnalyst RevisionGap Down0.18%NGNENeurogene$19.76-3.1%3.4758 of 5 stars2.71$45.40 129.8%7News CoverageAnalyst ForecastGap Down0.15%AZTAAzenta$30.60+0.6%3.423 of 5 stars2.50$50.67 65.6%4Positive NewsGap Down0.09%VYGRVoyager Therapeutics$3.30-8.3%4.4153 of 5 stars3.13$13.39 305.8%8News CoverageAnalyst Revision This page (BATS:HELX) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HELX Stock Free HELX Stock Alerts